Neoplasia (New York, N.Y.) - JoVE Visualize

Showing results (321-330 of 2,751) with videos related to

Pageof 276

Sort By:

Neoplasia (New York, N.Y.)|February 18, 2004

A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markersAnjali Shiras, Arti Bhosale, Varsha Shepal, et al.

Neoplasia (New York, N.Y.)|March 16, 2002

In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vaginaG Schönfelder, B Flick, E Mayr, et al.

Neoplasia (New York, N.Y.)|October 26, 2005

Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatmentSilke Wemmert, Ralf Ketter, Jörg Rahnenführer, et al.

Neoplasia (New York, N.Y.)|October 26, 2005

Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor modelsAxel Kleespies, Gudrun Köhl, Michael Friedrich, et al.

Neoplasia (New York, N.Y.)|October 19, 2005

The identification of senescence-specific genes during the induction of senescence in prostate cancer cellsSteven R Schwarze, Vivian X Fu, Joshua A Desotelle, et al.

Neoplasia (New York, N.Y.)|October 19, 2005

Regulation of glioma cell migration by serine-phosphorylated P311Wendy S McDonough, Nhan L Tran, Michael E Berens

Neoplasia (New York, N.Y.)|December 16, 2005

BJ-TSA-9, a novel human tumor-specific gene, has potential as a biomarker of lung cancerYunyan Li, Xueyuan Dong, Yanhui Yin, et al.

Neoplasia (New York, N.Y.)|December 16, 2005

Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1Gelareh Zadeh, Rob Reti, Keyvan Koushan, et al.

Neoplasia (New York, N.Y.)|December 16, 2005

Combination of proteasomal inhibitors lactacystin and MG132 induced synergistic apoptosis in prostate cancer cellsRobert B Shirley, Ismail Kaddour-Djebbar, Dimpu M Patel, et al.

Neoplasia (New York, N.Y.)|January 15, 2010

INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell supportJun Li, Margaret Favata, Jennifer A Kelley, et al.

Pageof 276

Showing results (321-330 of 2,751) with videos related to

Sort By:

Pageof 276

Neoplasia (New York, N.Y.)|February 18, 2004

A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markersAnjali Shiras, Arti Bhosale, Varsha Shepal, et al.

Neoplasia (New York, N.Y.)|March 16, 2002

In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vaginaG Schönfelder, B Flick, E Mayr, et al.

Neoplasia (New York, N.Y.)|October 26, 2005

Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatmentSilke Wemmert, Ralf Ketter, Jörg Rahnenführer, et al.

Neoplasia (New York, N.Y.)|October 26, 2005

Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor modelsAxel Kleespies, Gudrun Köhl, Michael Friedrich, et al.

Neoplasia (New York, N.Y.)|October 19, 2005

The identification of senescence-specific genes during the induction of senescence in prostate cancer cellsSteven R Schwarze, Vivian X Fu, Joshua A Desotelle, et al.

Neoplasia (New York, N.Y.)|October 19, 2005

Regulation of glioma cell migration by serine-phosphorylated P311Wendy S McDonough, Nhan L Tran, Michael E Berens

Neoplasia (New York, N.Y.)|December 16, 2005

BJ-TSA-9, a novel human tumor-specific gene, has potential as a biomarker of lung cancerYunyan Li, Xueyuan Dong, Yanhui Yin, et al.

Neoplasia (New York, N.Y.)|December 16, 2005

Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1Gelareh Zadeh, Rob Reti, Keyvan Koushan, et al.

Neoplasia (New York, N.Y.)|December 16, 2005

Combination of proteasomal inhibitors lactacystin and MG132 induced synergistic apoptosis in prostate cancer cellsRobert B Shirley, Ismail Kaddour-Djebbar, Dimpu M Patel, et al.

Neoplasia (New York, N.Y.)|January 15, 2010

INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell supportJun Li, Margaret Favata, Jennifer A Kelley, et al.

Pageof 276